Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability
USA - English
- Preliminary results for the full year of 2020: Order intake up 49.0 percent; sales revenue up 30.2 percent; underlying EBITDA margin climbs to 29.6 percent
- Bioprocess Solutions Division with a sharp rise in sales revenue and earnings and a key role as a provider of essential technologies for vaccine production
- Significant double-digit growth in the Lab Products & Services Division despite a challenging first half due to the pandemic
- Number of employees rises by 17.7 percent to more than 10,600
- Strong outlook for 2021: Sales revenue set to increase by 19 percent to 25 percent
Software AG: Software AG bookings growth beats guidance; driven by accelerating subscription shift
Darmstadt (pta006/27.01.2021/01:42) - Software AG bookings growth beats guidance; driven by accelerating subscription shift
- Bookings growth of 31 percent fourth quarter and 24 percent full year 2020 driven by transformation success -
- Group maintains commitment to stated mid-term 2023 ambitions -
Darmstadt, Germany - January 27, 2021: Software AG (Frankfurt MDAX®: SOW) today announces financial results for the fourth quarter and full year 2020 and issues guidance for the 2021 financial year. Our strong fourth quarter results capped off an outstanding year delivered despite major challenges. Our transformation is forging ahead, with our focused product set and enhanced execution capability driving our subscription shift beyond our original plan and helping us win against competition. In 2021 we plan to accelerate our transformation and push for continued growth. I m extremely
Share this article
Share this article
LUND, Sweden, Jan. 27, 2021 /PRNewswire/ Hansa Biopharma will publish its Year-End report 2020 at 8:00 CET on February 4, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/2:00pm EST.
The event will be hosted by Hansa Biopharma s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
Slides used in the presentation will be live on the company website during the call under Events & Webcast, and will also be made available online after the call.
CET- Comunicado - ;ultimaHoraHtml += + json.lead + ;}ultimaHoraHtml += ; document.getElementById( urgente ).innerHTML = ultimaHoraHtml; } } });
Zurich, 27 January 2021 / News Aktuell.- ThomasLloyd announced today that SolarArise India Projects Private Limited (“SolarArise”) has commissioned a 75 Megawatt (“MW”) Solar PV plant in Khera village, Budaun District, state of Uttar Pradesh delivering clean energy to over 100,000 people in Northern India.
In 2018, ThomasLloyd, a leader in impacting investing in emerging markets, invested in Delhi-based SolarArise alongside the Global Energy Efficiency and Renewable Energy Fund (“GEEREF”), advised by the European Investment Bank Group, and Kotak Mahindra managed Core Infrastructure India Fund (“CIIF”).
The new solar plant operates under Talettutayi Solar Projects Five Private Limited has a 25-year Power Purchase Agreement (“PPA”) with the state government
NIMC Begins Enrolment of Diplomats thisdaylive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisdaylive.com Daily Mail and Mail on Sunday newspapers.